Heavy/light chain ratio for the assessment of minimal residual disease in myeloma patients achieving complete response

Br J Haematol. 2018 May;181(4):550-552. doi: 10.1111/bjh.14662. Epub 2017 Apr 25.
No abstract available

Publication types

  • Comparative Study
  • Evaluation Study
  • Letter

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Humans
  • Immunoglobulin Heavy Chains / blood*
  • Immunoglobulin Light Chains / blood*
  • Male
  • Middle Aged
  • Multiple Myeloma / blood*
  • Multiple Myeloma / pathology
  • Multiple Myeloma / therapy*
  • Neoplasm Proteins / blood*
  • Neoplasm, Residual
  • Prospective Studies

Substances

  • Immunoglobulin Heavy Chains
  • Immunoglobulin Light Chains
  • Neoplasm Proteins